Michael Jaffe, MD
Pain Medicine · Salt Lake City, UTNPI 1730119801
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Relievant Medsystems, Inc. at 30.1% of the total. Reporting peaked in 2019 at $251 and has fallen 60.9% since, to $98 in 2024. That places this record below the midpoint for pain medicine clinicians in UT, where the typical reported total is $3,451.
Across 18 payments — averaging $30.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$167
- Ipsen Biopharmaceuticals, Inc$100
- Biohaven Pharmaceutical Holding Company Ltd.$55
- Boston Scientific$43
- Indivior Inc.$33
- Nevro Corp.$29
- plus $129 from 7 others
What the payments were for
- Food & beverage$555100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$151
How this compares
$555 in reported general payments places this provider in the 20th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 39 | $7,583 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 142 | $3,662 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 69 | $3,077 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $1,209 |
| Buprenorphine Hcl | 28 | $919 |
| Pregabalin | 40 | $843 |
| Gabapentin | 44 | $783 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $736 |
| Tramadol Hcl | 33 | $521 |
| Hydromorphone Hcl | 26 | $349 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $317 |
| Cyclobenzaprine Hcl | 12 | $92 |
| Clonazepam | 13 | $24 |
| Meloxicam | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Salt Lake City
- Maria SchwartzSalt Lake City$813K
- Lynn WebsterSalt Lake City$160K
- Austin AlbrightSalt Lake City$14K
- Kristina ReedSalt Lake City$4K
- Shonte McKenzieSalt Lake City$3K
- Perry FineSalt Lake City$3K
- Mathew RomankowskiSalt Lake City$2K
- Adam EddingtonSalt Lake City$780
- Natalie WinterSalt Lake City$586
- Nicholas DaleySalt Lake City$362
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.